Viewing Study NCT00681850


Ignite Creation Date: 2025-12-24 @ 5:04 PM
Ignite Modification Date: 2026-02-21 @ 8:27 PM
Study NCT ID: NCT00681850
Status: COMPLETED
Last Update Posted: 2020-01-22
First Post: 2008-05-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: OPtimal Type 2 dIabetes Management Including Benchmarking and Standard trEatment.
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetes View
None Benchmarking View
None quality of patient care View
None Diabetic Population View